CASPONEB - Phase II safety lead-in randomized blind placebo controlled clinical trial : efficacy and safety of caspofungin aerosols for the curative treatment of Pneumocystis pneumonia in adjunction of conventional systemic antifungal therapy

2023-508861-34-00 Protocol DR220214 Phase I and Phase II (Integrated) - Other Ongoing, recruiting

Start 2 Dec 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 3 sites · Protocol DR220214

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruiting
Participants planned 96
Countries 1
Sites 3

Pneumocystis pneumonia

Key facts

Sponsor
Centre Hospitalier Regional Universitaire De Tours
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Parasitic Diseases [C03]
Trial duration
2 Dec 2025 → ongoing
Decision date (initial)
2025-02-25
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Pneumocystis pneumonia

VersionLevelCodeTermSystem organ class
20.0 PT 10073755 Pneumocystis jirovecii pneumonia 100000004862

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centre Hospitalier Regional Universitaire De Tours

Sponsor organisation
Centre Hospitalier Regional Universitaire De Tours
Address
2 Boulevard Tonnelle
City
Tours
Postcode
37000
Country
France

Scientific contact point

Organisation
Centre Hospitalier Regional Universitaire De Tours
Contact name
Project leader

Public contact point

Organisation
Centre Hospitalier Regional Universitaire De Tours
Contact name
Project leader

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 96 3
Rest of world 0

Investigational sites

France

3 sites · Ongoing, recruiting
Centre Hospitalier Regional D'Orleans
Intensive care, 14 Avenue De L Hopital, Cs 86709, Orleans Cedex 2
Centre Hospitalier Regional Universitaire De Tours
Intensive care, 2 Boulevard Tonnelle, 37044, Tours Cedex 9
Centre Hospitalier Regional Universitaire De Tours
Infectious diseases, 2 Boulevard Tonnelle, 37044, Tours Cedex 9

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2025-12-02 2025-12-02

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-10-23 France Acceptable
2025-01-31
2025-02-25